Comparing cardiovascular benefits of sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in older adults with diabetes
Publication
, Conference
Htoo, P; Buse, J; Wang, T; Pate, V; Crowley, M; Sturmer, T
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
2020
Duke Scholars
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
2020
Volume
29
Start / End Page
138 / 139
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Htoo, P., Buse, J., Wang, T., Pate, V., Crowley, M., & Sturmer, T. (2020). Comparing cardiovascular benefits of sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in older adults with diabetes. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 29, pp. 138–139).
Htoo, Phyo, John Buse, Tiansheng Wang, Virginia Pate, Matthew Crowley, and Til Sturmer. “Comparing cardiovascular benefits of sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in older adults with diabetes.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 29:138–39, 2020.
Htoo P, Buse J, Wang T, Pate V, Crowley M, Sturmer T. Comparing cardiovascular benefits of sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in older adults with diabetes. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020. p. 138–9.
Htoo, Phyo, et al. “Comparing cardiovascular benefits of sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in older adults with diabetes.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 29, 2020, pp. 138–39.
Htoo P, Buse J, Wang T, Pate V, Crowley M, Sturmer T. Comparing cardiovascular benefits of sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in older adults with diabetes. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020. p. 138–139.
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
2020
Volume
29
Start / End Page
138 / 139
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences